查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417393

全球內視鏡逆行性造影(ERCP) 市場：趨勢、預測與競爭分析（~2030 年）

Endoscopic Retrograde Cholangiopancreatography Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

內視鏡逆行性造影的趨勢與預測

至2030年，全球內視鏡逆行性造影市場規模預計將達19億美元，2024年至2030年年複合成長率為5.5%。該市場的主要驅動力是癌症發病率上升、對微創手術/手術的日益偏好以及政府和醫療機構不斷增加的財務承諾。全球內視鏡逆行性造影市場的未來充滿希望，醫院和門診手術中心/診所市場充滿機會。

內視鏡逆行性造影市場洞察

Lucintel 預測，由於胃腸道疾病的盛行率不斷增加，內視鏡治療設備在預測期內仍將是最大的細分市場。

在這個市場中，醫院可能仍然是最大的細分市場，因為這些設施中提供了廣泛的 ERCP 設備。

由於癌症患者數量的增加和先進 ERCP 工具的引入，在預測期內，北美可能仍然是最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球內視鏡逆行性造影市場預計將達到 19 億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球內視鏡逆行性造影市場預計將以5.5%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是癌症發病率上升、對微創手術和手術的日益偏好以及政府和醫療機構不斷增加的財政承諾。

Q4.市場的主要細分市場是什麼？

A4. 內視鏡逆行性造影市場的未來前景廣闊，醫院和門診手術中心/診所市場充滿機會。

Q5.市場上主要企業有哪些？

A5. 進行內視鏡逆行性造影的主要企業如下。

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於胃腸道疾病的盛行率不斷增加，內視鏡治療設備在預測期內仍將是其最大的細分市場。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於癌症患者的增加和先進的 ERCP 工具的引入，在預測期內，北美將繼續成為最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球內視鏡逆行性胰造影市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 市場趨勢及預測分析（2018-2030）

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球內視鏡逆行性造影市場趨勢（2018-2023）與預測（2024-2030）
  • 全球內視鏡逆行性胰造影市場：依產品
    • 內視鏡
    • 內視鏡治療裝置
    • 視覺化系統
    • 能源裝置
    • 其他
  • 全球內視鏡逆行性胰造影市場：依程序
    • 膽管括約肌切開術
    • 膽道置入術
    • 膽道透析
    • 胰臟括約肌切開術
    • 胰管支架置入術
    • 胰管擴張
  • 全球內視鏡逆行性胰造影市場：依最終用途分類
    • 醫院
    • 門診手術中心/診所
    • 其他

第4章市場趨勢與預測分析：按地區（2018-2030）

  • 全球內視鏡逆行性造影市場（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品
    • 按程式
    • 按最終用途
    • 按地區
  • 全球內視鏡逆行性造影市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球內視鏡逆行性造影市場的產能擴張
    • 全球內視鏡逆行性造影市場的合併、收購及合資企業
    • 認證和許可

第7章主要企業概況

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device
簡介目錄

Endoscopic Retrograde Cholangiopancreatography Trends and Forecast

The future of the global endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets. The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.

A more than 150-page report is developed to help in your business decisions.

Endoscopic Retrograde Cholangiopancreatography by Segment

The study includes a forecast for the global endoscopic retrograde cholangiopancreatography by product, procedure, end use, and region.

Endoscopic Retrograde Cholangiopancreatography Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Endoscopes
  • Endotherapy Devices
  • Visualization Systems
  • Energy Devices
  • Others

Endoscopic Retrograde Cholangiopancreatography Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dialtation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilatation

Endoscopic Retrograde Cholangiopancreatography Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers & Clinics
  • Other

Endoscopic Retrograde Cholangiopancreatography Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Endoscopic Retrograde Cholangiopancreatography Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endoscopic retrograde cholangiopancreatography companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endoscopic retrograde cholangiopancreatography companies profiled in this report include-

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device

Endoscopic Retrograde Cholangiopancreatography Market Insights

Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.

Within this market, hospital will remain the largest segment due to availability of wide range of ERCP devices in these facilities.

North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.

Features of the Global Endoscopic Retrograde Cholangiopancreatography Market

Market Size Estimates: Endoscopic retrograde cholangiopancreatography market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endoscopic retrograde cholangiopancreatography market size by product, procedure, end use, and region in terms of value ($B).

Regional Analysis: Endoscopic retrograde cholangiopancreatography market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, procedures, end uses, and regions for the endoscopic retrograde cholangiopancreatography market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endoscopic retrograde cholangiopancreatography market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the endoscopic retrograde cholangiopancreatography market size?

Answer: The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for endoscopic retrograde cholangiopancreatography market?

Answer: The global endoscopic retrograde cholangiopancreatography market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the endoscopic retrograde cholangiopancreatography market?

Answer: The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.

Q4. What are the major segments for endoscopic retrograde cholangiopancreatography market?

Answer: The future of the endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets.

Q5. Who are the key endoscopic retrograde cholangiopancreatography market companies?

Answer: Some of the key endoscopic retrograde cholangiopancreatography companies are as follows.

  • Hobbs Medical
  • STERIS
  • Merit Medical Systems
  • TeleMed Systems
  • Changzhou Health Microport Medical Device

Q6. Which endoscopic retrograde cholangiopancreatography market segment will be the largest in future?

Answer: Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.

Q7. In endoscopic retrograde cholangiopancreatography market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the endoscopic retrograde cholangiopancreatography market by product (endoscopes, endotherapy devices, visualization systems, energy devices, and others), procedure (biliary sphincterotomy, biliary stenting, biliary dialtation, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct dilatation), end use (hospitals, ambulatory surgery centers & clinics, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Endoscopic Retrograde Cholangiopancreatography Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Endoscopic Retrograde Cholangiopancreatography Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Endoscopic Retrograde Cholangiopancreatography Market by Product
    • 3.3.1: Endoscopes
    • 3.3.2: Endotherapy Devices
    • 3.3.3: Visualization Systems
    • 3.3.4: Energy Devices
    • 3.3.5: Others
  • 3.4: Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
    • 3.4.1: Biliary Sphincterotomy
    • 3.4.2: Biliary Stenting
    • 3.4.3: Biliary Dialtation
    • 3.4.4: Pancreatic Sphincterotomy
    • 3.4.5: Pancreatic Duct Stenting
    • 3.4.6: Pancreatic Duct Dilatation
  • 3.5: Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgery Centers & Clinics
    • 3.5.3: Other

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Endoscopic Retrograde Cholangiopancreatography Market by Region
  • 4.2: North American Endoscopic Retrograde Cholangiopancreatography Market
    • 4.2.2: North American Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
  • 4.3: European Endoscopic Retrograde Cholangiopancreatography Market
    • 4.3.1: European Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
    • 4.3.2: European Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
  • 4.4: APAC Endoscopic Retrograde Cholangiopancreatography Market
    • 4.4.1: APAC Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
    • 4.4.2: APAC Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
  • 4.5: ROW Endoscopic Retrograde Cholangiopancreatography Market
    • 4.5.1: ROW Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
    • 4.5.2: ROW Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Product
    • 6.1.2: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
    • 6.1.3: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
    • 6.1.4: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Region
  • 6.2: Emerging Trends in the Global Endoscopic Retrograde Cholangiopancreatography Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Endoscopic Retrograde Cholangiopancreatography Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endoscopic Retrograde Cholangiopancreatography Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hobbs Medical
  • 7.2: STERIS
  • 7.3: Merit Medical Systems
  • 7.4: TeleMed Systems
  • 7.5: Changzhou Health Microport Medical Device